Data Type
Cell Information
(858)
Citations
(4902)
FAQ
(515)
Culture Media
(69)
Category
Transfection
(760)
Cell Lines and Primary Cancer Cells
(586)
Primary Cells and Media
(258)
3D Cell Culture
(15)
Protozoa
(11)
Classical Media and Reagents
(7)
Serum-free and Speciality Media
(2)
Cell Services
(1)
Live Cell Imaging
(1)
+ Show All
Research Area
Cancer Research/Cell Biology
(539)
Immunotherapy / Hematology
(254)
Dermatology/Tissue Engineering
(125)
Neurobiology
(86)
Gastroenterology
(67)
Cardiovascular
(52)
Stem Cells
(43)
Basic Research
(19)
Parasitology
(11)
Regenerative medicine
(6)
Toxicology
(6)
Gene Expression
(4)
Respiratory Research
(4)
Molecular Biology
(1)
+ Show All
Platform
Nucleofector® I/II/2b
(713)
4D-Nucleofector® X-Unit
(276)
4D-Nucleofector® 96-well Systems
(161)
4D-Nucleofector® Y-Unit
(35)
384-well HT Nucleofector® System
(10)
4D-Nucleofector® LV-Unit
(1)
Species
human
(523)
mouse
(183)
rat
(67)
monkey
(15)
bovine
(11)
hamster
(10)
unicellular
(9)
porcine
(8)
chicken
(7)
canine
(6)
rabbit
(3)
baboon
(2)
cell hybrid
(2)
fish
(2)
spodoptera frugiperda (army fall worm)
(2)
Trichopulsia ni (Cabbage Looper)
(1)
drosophila melanogaster (fruit fly)
(1)
equine
(1)
feline
(1)
ferret
(1)
potoroo
(1)
sheep
(1)
+ Show All
Characteristic
Adherent
(458)
Suspension
(399)
858 results sorted by
relevance
alphabetical
newest first
oldest first
ATDC5
pre-chondrocytic; teratocarcinoma
See Transfection Data
AtT20
pituitary gland adenoma
See Transfection Data
HT22
immortalized mouse hippocampal cell line
See Transfection Data
RBL
basophilic leukemia cells
See Transfection Data
HPB-ALL
human, Japanese, peripheral blood, leukemia, T cell
See Transfection Data
697
human, bone marrow, leukemia, pre-B cell
See Transfection Data
CH27
mouse B cell lymphoma cells
See Transfection Data
Colo201
human colon adenocarcinoma
See Transfection Data
BCL1.3B3
murine B cell leukemia
See Transfection Data
Colo205
human colon adenocarcinoma
See Transfection Data
PREVIOUS
PAGE
13
PAGE
14
PAGE
15
PAGE
16
PAGE
17
PAGE
18
PAGE
19
PAGE
20
PAGE
21
NEXT